OmniAb Results Presentation Deck

Active Partners Q1 2023: 70 ACTIVE PARTNERS 70 60 50 40 30 20 10 0 Number of Active Partners 2017 2018 2019 2016 2020 2021 2022 3/31/2023 ● ● New license and revenue sharing agreement signed in Q1 with Scripps Strong annual growth in key performance indicators continues, net of attrition Active Partners: -18% CAGR 2016 through 2022 Partner progression can lead to consolidation (e.g. Seagen-Pfizer) Represents the unique number of partners that have an active program or have executed a license agreement in advance of initiating an active program LO 5 OmniAb

View entire presentation